Drugs / poliovirus (Live) vaccine type I \& type III (Human Diploid cell)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03822767 Background | Jun → Sep 2018 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | poliovirus (Live) vaccine type I \& type III (Human Diploid cell) | “The poliovirus (Live) vaccine type I \& type III (Human Diploid cell) ( bOPV) was manufactured by Beijing Bio-institute Biological Products Co., Ltd.” NCT03822767 ↗ |
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03822767 ↗ |
| Modality | Vaccine | “bivalent oral poliovirus vaccine” NCT03822767 ↗ |
| Route | Oral | “bivalent oral poliovirus vaccine” NCT03822767 ↗ |